{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-050528","form_type":"8-K","ticker":"HYPD","cik":"0001682639","company_name":"HYPERION DEFI, INC.","filed_at":"2025-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.327314+00:00","generated_at":"2026-05-21T01:49:00.944582+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Eyenovia Reports Q1 2025 Financial Results, Provides Merger and Optejet Development Update","bullets":["Net loss narrowed to $3.5 million ($1.59 per share) versus $10.9 million ($18.75 per share) in Q1 2024.","Continuing merger negotiations with Betaliq; binding exclusivity extended to June 7, 2025.","Optejet user-filled device on track to file for FDA device approval in September 2025.","Cash burn reduced by approximately 70% versus prior year; debt restructuring with Avenue Capital defers payments to October 2025.","Unrestricted cash and equivalents totaled $3.9 million as of March 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-050528","json":"https://secwatch.observer/filing/0001104659-25-050528.json","markdown":"https://secwatch.observer/filing/0001104659-25-050528.md","text":"https://secwatch.observer/filing/0001104659-25-050528.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925050528/0001104659-25-050528-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682639/000110465925050528/tm2515543d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-21T01:49:00.944582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}